Market Research Report
Hyperbaric Oxygen Therapy (HBOT) Devices Market - Growth, Trends, and Forecast (2019 - 2024)
|Published by||Mordor Intelligence LLP||Product code||802329|
|Published||Content info||111 Pages
Delivery time: 2-3 business days
|Hyperbaric Oxygen Therapy (HBOT) Devices Market - Growth, Trends, and Forecast (2019 - 2024)|
|Published: March 1, 2019||Content info: 111 Pages||
The hyperbaric oxygen therapy (HBOT) devices market is majorly driven by the rising prevalence of acute and chronic wounds, widening the application of HBOT devices in cosmetic procedures and wound healing, and technological advancements.
HBOT devices are used in chronic problem wounds caused by diabetes, venous or arterial insufficiency, crush injuries, and wounds/tissue damage caused by the late effects of radiation therapy. The chronic wounds impose a significant burden on the individual, the healthcare system, and the society as a whole. According to the estimates of the National Health Services (NHS), 1.5% of the UK population is estimated to have a leg ulcer. Furthermore, as per the NHS Benchmarking 2016 annual audit, approximately 39% of a district nursing service workload is attributed to wound care. The annual cost of managing wounds in the NHS and associated comorbidities has been estimated to be EUR 5.3 billion, which is more than what is on par with the obesity treatment costs, according to the study published in 2017 by Guest J, Venous Leg Ulcer Management in Clinical Practice in the UK: Costs and Outcomes. Thus, the rising incidences and prevalence of acute and chronic wounds are expected to drive the growth of the hyperbaric oxygen therapy (HBOT) devices market over the forecast period.
As per the scope of this report, the term hyperbaric oxygen therapy implicates breathing oxygen in pressurized chambers, where the atmospheric pressure is thrice higher than normal, thus, allowing the lungs to absorb three times more oxygen than in normal air pressure. Hyperbaric oxygen therapy augments the quantity of oxygen, which may improve vital tissue function in recovery from injuries and fight infection.
Monoplace HBOT is the Segment Under Application that is Expected to Grow Fastest During the Forecast Period
The monoplace HBOT segment held a maximum share in 2018, due to factors, like commercial availability of monoplace systems and high adoption of such devices, due to ease of handling and less requirement of hospital gas supply. The market is majorly dominated by few products, such as BARA-MEDXD, BARA-MED, BARA-MED Select by ETC Hyperbaric Chambers (Environmental Tectonics Corporation); PAH-S1 Hyperbaric Chamber & PAH-S1-3800 Hyperbaric Chamber by Pan-America Hyperbarics Inc.
The monoplace HBOT devices segment is expected to register a high growth rate during the forecast period, due to the rising demand for monoplace systems in hospitals and clinics, due to their higher availability in the market, along with ease in installation.
North American Region Holds the Largest Share of the Market Currently and is Believed to Follow the Same Trend over the Forecast Period
The North American region is expected to dominate the market, owing to factors, such as rising disposable income, increasing population, and the rising need for wound healing treatment, which have impelled the demand for HBOT in the region. According to the National Institutes of Health, human skin wound is a significant indirect threat to the economy, as the government takes responsibility for the treatment of the public. This has led the government to invest huge amounts of money toward developing effective treatment methods. Research in the United States has revealed that the incidence of non-healing cutaneous wounds is about 5 to 7 million per year, in the country. The relative spending for these wounds is about USD 25 billion. The cost burden to the US healthcare system has been so severe that the medical services and centers for medical care have made amendments to the reimbursement policy for wound care, providing economic incentives for hospitals, in order to improve and reduce costs. All of the aforementioned factors are expected to propel the growth of the hyperbaric oxygen therapy (HBOT) devices market.
The hyperbaric oxygen therapy (HBOT) devices market is moderately competitive and consists of several major players. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market positions.